Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 285-377-1 | CAS number: 85085-48-9 Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Melaleuca alternifolia, Myrtaceae.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.658 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 37.5
- Dose descriptor starting point:
- NOAEC
- Value:
- 20 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 24.684 mg/m³
- Explanation for the modification of the dose descriptor starting point:
Starting point correction formula:
Corrected dose descriptor = oral NOAEL x 1/sRVan x Diff. exp. cond. x (ABSoral,an/ABSinh,hu) x sRVhu/wRV
Given:
Experimental animal: rat
Relevant human exposure route: inhalation
Oral NOAEL from original study (oral NOAEL) = 20 mg/kg bw/day (test result)
Standard respiratory volume, animal (sRVan) = 0.38 m3/kg bw/8 h (default)
Standard respiratory volume, human (sRVhu) = 6.7 m3 / person (default)
Differences in experimental/human exposure conditions (Diff exp. cond) = 1.4 (default)
Oral to inhalation extrapolation between animals and humans (ABSoral,an/ABSinh,hu) = 0.5 (default)
Worker respiratory volume (wRV) = 10 m3 / person (default)
Corrected dose descriptor:
corr inh NOAEC: 24.684 mg/m3
- AF for dose response relationship:
- 1
- Justification:
- The dose descriptor is an NOAEL.
- AF for differences in duration of exposure:
- 3
- Justification:
- Default for sub-acute to sub-chronic exposure.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Default for systemic effects by the inhalation route.
- AF for other interspecies differences:
- 2.5
- Justification:
- Default for systemic effects for other interspecies differences.
- AF for intraspecies differences:
- 5
- Justification:
- Default value for workers.
- AF for the quality of the whole database:
- 1
- Justification:
- Default applied to good quality/standard databases.
- AF for remaining uncertainties:
- 1
- Justification:
- Default applied to good quality/standard databases.
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.658 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 37.5
- DNEL extrapolated from long term DNEL
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 4.356 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 150
- Dose descriptor starting point:
- NOAEL
- Value:
- 20 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 653.33 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
Starting point correction formula:
Corrected dose descriptor = oral NOAEL x Diff. exp. cond. x (ABSoral,an/ABSderm,hu)
Given:
Experimental animal: rat
Relevant human exposure route: dermal
Oral NOAEL from original study (oral NOAEL) = 20 mg/kg bw/day (test result)
Differences in experimental/human exposure conditions (Diff exp. cond) = 1.4 (default)
Oral to dermal extrapolation between animals and humans (ABSoral,an/ABSderm,hu) = 23.33 (based on 70% absortion via the oral route and 3% absorption via the dermal route)
Corrected dose descriptor:
corr dermal NOAEL: 653.33 mg/kg bw/d
- AF for dose response relationship:
- 1
- Justification:
- The dose descriptor is an NOAEL.
- AF for differences in duration of exposure:
- 3
- Justification:
- Default for sub-acute to sub-chronic exposure.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Default for systemic effects by the dermal route.
- AF for other interspecies differences:
- 2.5
- Justification:
- Default for systemic effects for other interspecies differences.
- AF for intraspecies differences:
- 5
- Justification:
- Default value for workers.
- AF for the quality of the whole database:
- 1
- Justification:
- Default applied to good quality/standard databases.
- AF for remaining uncertainties:
- 1
- Justification:
- Default applied to good quality/standard databases.
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 4.356 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 150
- DNEL extrapolated from long term DNEL
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.296 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 75
- Dose descriptor starting point:
- NOAEC
- Value:
- 20 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 22.222 mg/m³
- Explanation for the modification of the dose descriptor starting point:
Starting point correction formula:
Corrected dose descriptor = oral NOAEL x 1/sRVan x Diff. exp. cond. x (ABSoral,an/ABSinh,hu)
Given:
Experimental animal: rat
Relevant human exposure route: inhalation
Oral NOAEL from original study (oral NOAEL) = 20 mg/kg bw/day (test result)
Standard respiratory volume, animal (sRVan) = 0.45 m3/kg bw/8 h (default)
Standard respiratory volume, human (sRVhu) = 6.7 m3 / person (default)
Differences in experimental/human exposure conditions (Diff exp. cond) = 1 (default)
Oral to inhalation extrapolation between animals and humans (ABSoral,an/ABSinh,hu) = 0.5 (default)
Corrected dose descriptor:
corr inh NOAEC: 22.222 mg/m3
- AF for dose response relationship:
- 1
- Justification:
- The dose descriptor is an NOAEL.
- AF for differences in duration of exposure:
- 3
- Justification:
- Default for sub-acute to sub-chronic exposure.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- Default for systemic effects by the inhalation route.
- AF for other interspecies differences:
- 2.5
- Justification:
- Default for systemic effects for other interspecies differences.
- AF for intraspecies differences:
- 10
- Justification:
- Default value for general population.
- AF for the quality of the whole database:
- 1
- Justification:
- Default applied to good quality/standard databases.
- AF for remaining uncertainties:
- 1
- Justification:
- Default applied to good quality/standard databases.
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.296 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 75
- DNEL extrapolated from long term DNEL
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1.556 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 300
- Dose descriptor starting point:
- NOAEL
- Value:
- 20 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 466.667 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
Starting point correction formula:
Corrected dose descriptor = oral NOAEL x Diff. exp. cond. x (ABSoral,an/ABSderm,hu)
Given:
Experimental animal: rat
Relevant human exposure route: dermal
Oral NOAEL from original study (oral NOAEL) = 20 mg/kg bw/day (test result)
Differences in experimental/human exposure conditions (Diff exp. cond) = 1 (default)
Oral to dermal extrapolation between animals and humans (ABSoral,an/ABSderm,hu) = 23.33 (based on 70% absortion via the oral route and 3% absorption via the dermal route)
Corrected dose descriptor:
corr dermal NOAEL: 466.667 mg/kg bw/d
- AF for dose response relationship:
- 1
- Justification:
- The dose descriptor is an NOAEL.
- AF for differences in duration of exposure:
- 3
- Justification:
- Default for sub-acute to sub-chronic exposure.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Default for systemic effects by the dermal route.
- AF for other interspecies differences:
- 2.5
- Justification:
- Default for systemic effects for other interspecies differences.
- AF for intraspecies differences:
- 10
- Justification:
- Default value for the general population.
- AF for the quality of the whole database:
- 1
- Justification:
- Default applied to good quality/standard databases.
- AF for remaining uncertainties:
- 1
- Justification:
- Default applied to good quality/standard databases.
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1.556 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 300
- DNEL extrapolated from long term DNEL
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.067 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 300
- Dose descriptor starting point:
- NOAEL
- Value:
- 20 mg/kg bw/day
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 20 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
Starting point correction formula:
Corrected dose descriptor = oral NOAEL x Diff. exp. cond. x (ABSoral,an/ABSoral,hu)
Given:
Experimental animal: rat
Relevant human exposure route: oral
Oral NOAEL from original study (oral NOAEL) = 20 mg/kg bw/day (test result)
Differences in experimental/human exposure conditions (Diff exp. cond) = 1 (default)
Oral to oral extrapolation between animals and humans (ABSoral,an/ABSoral) = 1 (default)
Corrected dose descriptor:
corr dermal NOAEL: 20 mg/kg bw/d
- AF for dose response relationship:
- 1
- Justification:
- The dose descriptor is an NOAEL.
- AF for differences in duration of exposure:
- 3
- Justification:
- Default for sub-acute to sub-chronic exposure.
- AF for interspecies differences (allometric scaling):
- 4
- Justification:
- Default for systemic effects by the oral route.
- AF for other interspecies differences:
- 2.5
- Justification:
- Default for systemic effects for other interspecies differences.
- AF for intraspecies differences:
- 10
- Justification:
- Default value for the general population.
- AF for the quality of the whole database:
- 1
- Justification:
- Default applied to good quality/standard databases.
- AF for remaining uncertainties:
- 1
- Justification:
- Default applied to good quality/standard databases.
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.067 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 300
- DNEL extrapolated from long term DNEL
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.